Does AZATHIOPRINE Cause Malignant neoplasm progression? 32 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Malignant neoplasm progression have been filed in association with AZATHIOPRINE (AZATHIOPRINE). This represents 0.1% of all adverse event reports for AZATHIOPRINE.
32
Reports of Malignant neoplasm progression with AZATHIOPRINE
0.1%
of all AZATHIOPRINE reports
13
Deaths
8
Hospitalizations
How Dangerous Is Malignant neoplasm progression From AZATHIOPRINE?
Of the 32 reports, 13 (40.6%) resulted in death, 8 (25.0%) required hospitalization, and 8 (25.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AZATHIOPRINE. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does AZATHIOPRINE Cause?
Drug ineffective (8,076)
Off label use (5,358)
Drug intolerance (3,392)
Condition aggravated (2,832)
Rheumatoid arthritis (2,746)
Treatment failure (2,483)
Arthralgia (2,427)
Drug hypersensitivity (2,421)
Nausea (2,178)
Pneumonia (2,157)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which AZATHIOPRINE Alternatives Have Lower Malignant neoplasm progression Risk?
AZATHIOPRINE vs AZD-1222
AZATHIOPRINE vs AZELAIC ACID
AZATHIOPRINE vs AZELASTINE
AZATHIOPRINE vs AZELASTINE\FLUTICASONE
AZATHIOPRINE vs AZELNIDIPINE